These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10870744)

  • 1. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NMDA-receptor antagonist in pain therapy].
    Weber C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Aug; 33(8):475-83. PubMed ID: 9746842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists.
    Ebert B; Thorkildsen C; Andersen S; Christrup LL; Hjeds H
    Biochem Pharmacol; 1998 Sep; 56(5):553-9. PubMed ID: 9783723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.
    Hillhouse TM; Negus SS
    Eur J Pain; 2016 Sep; 20(8):1229-40. PubMed ID: 26914635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
    Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
    Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
    Popik P; Kozela E; Danysz W
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
    Wiesenfeld-Hallin Z
    Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.
    Suzuki M
    Curr Opin Anaesthesiol; 2009 Oct; 22(5):618-22. PubMed ID: 19535974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
    Baker AK; Hoffmann VL; Meert TF
    Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review.
    Fluyau D; Revadigar N; Pierre CG
    Drug Alcohol Depend; 2020 Mar; 208():107845. PubMed ID: 31978670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promise of N-methyl-D-aspartate receptor antagonists in fibromyalgia.
    Henriksson KG; Sörensen J
    Rheum Dis Clin North Am; 2002 May; 28(2):343-51. PubMed ID: 12122922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical role of NMDA receptor antagonists for the treatment of postoperative pain.
    De Kock MF; Lavand'homme PM
    Best Pract Res Clin Anaesthesiol; 2007 Mar; 21(1):85-98. PubMed ID: 17489221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine: relief from chronic pain through actions at the NMDA receptor?
    Meller ST
    Pain; 1996 Dec; 68(2-3):435-6. PubMed ID: 9121834
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
    Hao JX; Xu XJ
    Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to S.T. Meller: Ketamine: relief from chronic pain through actions at the NMDA receptor.
    Eide PK; Stubhaug A; Breivik H; Oye I
    Pain; 1997 Aug; 72(1-2):289-91. PubMed ID: 9272819
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
    Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
    Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.